Cargando…
Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study
MiR-34a acts as tumor-suppressor by targeting many oncogenes related to proliferation, apoptosis, and invasion of gliomas. We studied the relationships between health-related quality of life (HRQOL), depression, and miR-34a expression status in patients with newly diagnosed glioblastoma (GBM). A com...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468714/ https://www.ncbi.nlm.nih.gov/pubmed/30836600 http://dx.doi.org/10.3390/cancers11030300 |
_version_ | 1783411497315074048 |
---|---|
author | Vaitkiene, Paulina Pranckeviciene, Aiste Stakaitis, Rytis Steponaitis, Giedrius Tamasauskas, Arimantas Bunevicius, Adomas |
author_facet | Vaitkiene, Paulina Pranckeviciene, Aiste Stakaitis, Rytis Steponaitis, Giedrius Tamasauskas, Arimantas Bunevicius, Adomas |
author_sort | Vaitkiene, Paulina |
collection | PubMed |
description | MiR-34a acts as tumor-suppressor by targeting many oncogenes related to proliferation, apoptosis, and invasion of gliomas. We studied the relationships between health-related quality of life (HRQOL), depression, and miR-34a expression status in patients with newly diagnosed glioblastoma (GBM). A comprehensive HRQOL assessment was completed by 38 patients with glioblastoma prior to surgical resection and included the European Organization for Research and Treatment of Cancer (EORTC) questionnaire for cancer patients (QLQ-C30) and the Brain Cancer-Specific Quality of Life Questionnaire (QLQ-BN20), the Patient Health Questionnaire-9 (PHQ-9), the Karnofsky performance index (KPS), and The Glasgow Outcome Scale (GOS). The miR-34a expression in glioblastoma tissue was measured using quantitative reverse transcription PCR. Our findings show that lower miR-34a expression is significantly associated with higher tumor volume, worse physical functioning, lower KPS, and greater depressive symptom severity of GBM patients. Moreover, analysis reveals that miR-34a effects might be gender specific, as stronger relationships between miR-34a and patient functioning measures were observed in males when compared to females. Despite the fact that, due to small sample size, our results should be considered as preliminary, our study suggests that miR-34a is associated with tumor burden and can be important for health-related quality of life, functional status, and mood symptoms of glioblastoma patients. |
format | Online Article Text |
id | pubmed-6468714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64687142019-04-24 Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study Vaitkiene, Paulina Pranckeviciene, Aiste Stakaitis, Rytis Steponaitis, Giedrius Tamasauskas, Arimantas Bunevicius, Adomas Cancers (Basel) Article MiR-34a acts as tumor-suppressor by targeting many oncogenes related to proliferation, apoptosis, and invasion of gliomas. We studied the relationships between health-related quality of life (HRQOL), depression, and miR-34a expression status in patients with newly diagnosed glioblastoma (GBM). A comprehensive HRQOL assessment was completed by 38 patients with glioblastoma prior to surgical resection and included the European Organization for Research and Treatment of Cancer (EORTC) questionnaire for cancer patients (QLQ-C30) and the Brain Cancer-Specific Quality of Life Questionnaire (QLQ-BN20), the Patient Health Questionnaire-9 (PHQ-9), the Karnofsky performance index (KPS), and The Glasgow Outcome Scale (GOS). The miR-34a expression in glioblastoma tissue was measured using quantitative reverse transcription PCR. Our findings show that lower miR-34a expression is significantly associated with higher tumor volume, worse physical functioning, lower KPS, and greater depressive symptom severity of GBM patients. Moreover, analysis reveals that miR-34a effects might be gender specific, as stronger relationships between miR-34a and patient functioning measures were observed in males when compared to females. Despite the fact that, due to small sample size, our results should be considered as preliminary, our study suggests that miR-34a is associated with tumor burden and can be important for health-related quality of life, functional status, and mood symptoms of glioblastoma patients. MDPI 2019-03-04 /pmc/articles/PMC6468714/ /pubmed/30836600 http://dx.doi.org/10.3390/cancers11030300 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vaitkiene, Paulina Pranckeviciene, Aiste Stakaitis, Rytis Steponaitis, Giedrius Tamasauskas, Arimantas Bunevicius, Adomas Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title | Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title_full | Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title_fullStr | Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title_full_unstemmed | Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title_short | Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study |
title_sort | association of mir-34a expression with quality of life of glioblastoma patients: a prospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468714/ https://www.ncbi.nlm.nih.gov/pubmed/30836600 http://dx.doi.org/10.3390/cancers11030300 |
work_keys_str_mv | AT vaitkienepaulina associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy AT pranckevicieneaiste associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy AT stakaitisrytis associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy AT steponaitisgiedrius associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy AT tamasauskasarimantas associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy AT buneviciusadomas associationofmir34aexpressionwithqualityoflifeofglioblastomapatientsaprospectivestudy |